Medicine & Life Sciences
4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)
10%
Adenosine Triphosphate
7%
Atypical Hemolytic Uremic Syndrome
32%
Bacterial Toxins
12%
Blood Cells
32%
Blood Platelets
45%
Carrier Proteins
7%
Clusterin
14%
Complement Activation
52%
Complement C3-C5 Convertases
14%
Complement Factor H
18%
Complement Membrane Attack Complex
10%
Edetic Acid
7%
Endothelial Cells
25%
Enterohemorrhagic Escherichia coli
36%
Erythrocytes
17%
Escherichia coli Infections
11%
Exosomes
12%
Extracellular Vesicles
32%
Flow Cytometry
12%
Galactose
10%
globotriaosylceramide
7%
HeLa Cells
9%
Hemolysis
18%
Hemolytic-Uremic Syndrome
74%
Immunoglobulin A
9%
Inflammation
24%
Interleukin-6
7%
Kallikrein-Kinin System
13%
Kidney
21%
Kinins
31%
Leukocytes
20%
Lipopolysaccharides
11%
Mesangial Cells
11%
Monocytes
9%
Mutation
13%
Neutrophils
12%
Perfusion
7%
Platelet Activation
24%
Purinergic Receptors
12%
Serum
9%
Shiga Toxin
100%
Shiga-Toxigenic Escherichia coli
20%
Suramin
7%
Thromboplastin
23%
Thrombosis
13%
Thrombotic Microangiopathies
15%
Thrombotic Thrombocytopenic Purpura
11%
Vasculitis
25%
Virulence Factors
15%
Agriculture & Biology
bacterial toxins
13%
blood cells
12%
colitis
6%
enterohemorrhagic Escherichia coli
15%
hemolytic uremic syndrome
13%
pathogenesis
8%
renal failure
5%
Shiga toxin
13%
virulence
6%